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Abstract
Background
AMediterranean dietary pattern is widely recommended for the prevention of chronic dis-
ease. We sought to define the most likely effects of the Mediterranean diet on vascular dis-
ease and mortality.
Methods
We searched MEDLINE, EMBASE and the Cochrane Central Register without language
restriction for randomized controlled trials comparing Mediterranean to control diets. Data
on study design, patient characteristics, interventions, follow-up duration, outcomes and
adverse events were sought. Individual study relative risks (RR) were pooled to create sum-
mary estimates.
Results
Six studies with a total of 10950 participants were included. Effects on major vascular
events (n = 477), death (n = 693) and vascular deaths (n = 315) were reported for 3, 5 and 4
studies respectively. For one large study (n = 1000) there were serious concerns about the
integrity of the data. When data for all studies were combined there was evidence of protec-
tion against major vascular events (RR 0.63, 95% confidence interval 0.53–0.75), coronary
events (0.65, 0.50–0.85), stroke (0.65, 0.48–0.88) and heart failure (0.30, 0.17–0.56) but
not for all-cause mortality (1.00, 0.86–1.15) or cardiovascular mortality (0.90, 0.72–1.11).
After the study of concern was excluded the benefit for vascular events (0.69, 0.55–0.86)
and stroke (0.66, 0.48–0.92) persisted but apparently positive findings for coronary events
(0.73, 0.51–1.05) and heart failure (0.25, 0.05–1.17) disappeared.
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Conclusion
The Mediterranean diet may protect against vascular disease. However, both the quantity
and quality of the available evidence is limited and highly variable. Results must be inter-
preted with caution.
Introduction
Cardiovascular disease (CVD) is a leading cause of mortality worldwide accounting for one
quarter of the estimated 52 million deaths in 2010[1,2]. The burden of CVD varies between
regions and a proportion of this variability may be due to different dietary patterns[1,3].
Populations in the Mediterranean region have been reported to experience lower morbidity
and mortality rates from CVD compared with northern European populations[4], which has
been attributed to their consumption of a Mediterranean diet high in fruits and vegetables,
nuts and cereals, fish, olive oil, with moderate red wine consumption and minimal amounts of
red meat and dairy products[5–7]. In addition, the Mediterranean diet has been associated
with beneficial effects on CVD risk factors such as glycaemia, blood pressure and lipid levels
[8–10]. Two recent systematic reviews have showed some beneficial effects of the Mediterra-
nean diet on the metabolic syndrome and its constituents but neither have explored the effects
on vascular events or mortality[11,12].
Although there are randomized controlled trials (RCTs) assessing the effect of the Mediter-
ranean diet on the primary or secondary prevention of CVD[13,14] the largest of these trials
recorded just a few hundred events. There is also concern that one of the key trials supporting
the beneficial effects of the Mediterranean diet was seriously methodologically compromised
[15]. There is, therefore, real uncertainty about the data underpinning the value of the Mediter-
ranean diet to human health. We undertook this systematic review and meta-analysis to better
define the effects of the Mediterranean diet on cardiovascular events and mortality.
Materials and Methods
Data sources and searches
We performed a systematic review of the literature according to the PRISMA statement for the
conduct of meta-analyses of intervention studies (www.prisma-statement.org) (S1 File). Rele-
vant studies were identified by searching the following data sources: MEDLINE via Ovid (from
inception through February 2014), EMBASE (from inception through February 2014) and the
Cochrane Library database (Cochrane Central Register of Controlled Trials; no date restric-
tion), using relevant text words and medical subject headings (S2 File). The search was limited
to randomised controlled trials (RCTs) without language restriction. Reference lists from iden-
tified trials and review articles were manually scanned to identify any other relevant studies.
The clinicaltrials.gov website was also searched for RCTs that were registered as completed but
not yet published.
Study selection
The literature search, data extraction and quality assessment were conducted independently by
two authors using a standardised approach (TL and AW). All completed RCTs assessing the
effects of a Mediterranean diet compared to any control diet involving adults, with follow up
period longer than three months, that reported one or more of the relevant outcomes were
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eligible for inclusion. Although there is considerable variability, a diet with non-restricted fat
intake and with at least two of the following seven components was defined as a Mediterranean
style diet for the purposes of this review; 1) use of olive oil as the main cooking oil, 2) moderate
red wine consumption, 3) high consumption of nuts and/or legumes, 4) high consumption of
grains and cereals, 5) high consumption of fruits and vegetables, 6) high consumption of fish
with low consumption of meat and meat products and 7) low to moderate consumption of
milk and dairy products[16].
Data extraction and quality assessment
Published reports were obtained for each trial and standard information about each trial was
extracted into a spreadsheet. The data sought included summary metrics for each trial about
baseline patient characteristics (age, gender, history of diabetes, history of hypertension, mean
systolic and diastolic blood pressure levels, lipid levels, smoking status, body mass index and
history of cardiovascular disease), details of the dietary intervention, follow-up duration, out-
come events and adverse events. Study quality was judged according to the Cochrane risk of
bias assessment tool[17]. Any disagreement in extracted data was adjudicated by a third
reviewer (VP).
Outcomes
We sought data on total cardiovascular events (stroke, myocardial infarction, cardiovascular
mortality or a broadly comparable definition reported by the study), coronary events (fatal or
non-fatal myocardial infarction, coronary revascularization), cerebrovascular events (fatal or
non-fatal stroke), heart failure, total mortality, incidence of type 2 diabetes mellitus, end-stage
kidney disease, adverse effects (all adverse effects and serious adverse effects) and quality of
life.
Data synthesis and analysis
Individual study relative risks (RRs) and 95% confidence intervals (CIs) were calculated from
event numbers extracted from each trial. In calculating RRs, the total number of patients ran-
domized in each group was used as the denominator. If no events were reported in either treat-
ment or control group of any trial, 0.5 was used as the numerator. For the three arm
PREDIMED study[14], the olive oil supplement arm and the nuts supplement arm were jointly
considered as the treatment group whereas in the four arm study by Burr et al[18] only the
“fish and fruit” arm fulfilled the defined criteria for the Mediterranean diet and this was com-
pared to the “sensible eating” arm. Primary summary estimates of RRs were obtained using a
random fixed effects model. Given the small number of included trials, publication bias and
percentage of variability across studies attributable to heterogeneity beyond chance were not
assessed as these may be unreliable. A two-sided p-value less than 0.05 was considered statisti-
cally significant. All analyses were performed with STATA, version 9.2 (Stata, College Station,
Texas).
Results
Search results and characteristics of included studies
The literature search yielded 4637 articles, of which 51 were reviewed in full text (Fig 1). Of
these, six RCTs, involving a total of 10950 participants, met the inclusion criteria. Among
these, 477 major cardiovascular events were reported from three trials[13,14,19] and 693
deaths from five trials[13,14,18–20]. The remaining study assessed the effect on quality of life
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[21]. The majority of the excluded trials did not study the Mediterranean diet as defined in the
protocol, studied only individual components of the Mediterranean diet, did not report rele-
vant outcomes, were not original investigations or were duplicate reports (S3 File).
The trials had a sample size that ranged from 48 to 7447 participants (Table 1). Two studies
were single-centre[13,20] and four were multi-centre[14,18,19,21]. All studies provided dietary
advice to participants and two studies provided food supplements in addition to dietary advice
[13,14]. The studies were conducted between March 1988 and December 2010. The mean age
of the study participants ranged between 41 and 67 years. One study only enrolled men[18],
one study only enrolled women[21] and four studies enrolled both men and women
[13,14,19,20]. Primary prevention was the objective of three studies[14,20,21], secondary pre-
vention was the goal of two studies[13,18] and the remaining study included patients with and
without a prior history of cardiovascular disease[19].
In regard to study quality (Table 2), four of the six studies concealed the randomized alloca-
tion sequence[13,14,19,20], no studies were double-blinded and blinded assessments of out-
comes were made in only 3 studies[13,14,19]. For one study subsequent publications raised
Fig 1. Identification process for eligible studies.
doi:10.1371/journal.pone.0159252.g001
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serious concerns about the integrity such that the veracity of results was significantly in doubt
[15,19].
Effects of Mediterranean diet on vascular outcomes and death
Major cardiovascular events. Effects of the Mediterranean diet were reported for this out-
come by three trials[13,14,19] including 9052 participants and 477 events. The Mediterranean
diet was associated with a 37% relative reduction in the risk of major cardiovascular events (RR
063, 95% CI: 053–075, p< 0001) compared to control diet. Exclusion of the study with seri-
ous concerns about its integrity (n = 1000, 145 events) did not result in a change of overall
direction of the effect (RR 0.69, 95% CI 0.55–0.86, p< 0.001) (Fig 2).
Fatal outcomes. Data on all-cause mortality were available from 5 trials[13,14,18–20]
including 10671 participants and 693 deaths, four of which also separately reported data for
cardiovascular mortality (10623 participants and 315 deaths) [13,14,18,19]. The Mediterranean
diet had no clear effect on all-cause mortality (RR 100, 95% CI: 086–115, p = 097) or cardio-
vascular mortality (RR: 090, 95% CI: 072–111, p = 032) compared to control (Fig 2). Exclud-
ing the trial by Singh et al. further widened the confidence intervals (Fig 2). Across the various
subgroups of studies examined (S1 and S2 Figs), greater benefits were suggested in small, single
centre studies with incomplete follow-up.
Cause-specific cardiovascular outcomes. Three trials[13,14,19] reported 221 coronary
events and 167 cerebrovascular events. Use of the Mediterranean diet was associated with a rel-
ative risk of 065 (95% CI 0.50–085) (Fig 2) for coronary events and 065 (95% CI 048–088)
for cerebrovascular events. Only two studies[13,19] involving 1605 participants and reporting
56 events were available to provide an effect estimate for heart failure, showing a relative risk of
030 (95% CI: 017–056). Exclusion of the data from the trial by Singh et al resulted in null
findings for all of the cause specific outcomes except cerebrovascular events which continued
to remain significant (RR: 066, 95% CI: 048–092, p = 001) (Fig 2).
Effects on other outcomes and adverse events. One study that enrolled 279 participants
reported data on quality of life[21]. There was a significant improvement with Mediterranean
diet as measured by the Problem Areas in Diabetes (PAID) [22] self-care summary score
(p = 0005) but no effect on any other domain of that score or the Medical Outcome Study
Table 2. Quality assessment of included studies.
Study/author
(year)
Random
sequence
generation
Allocation
concealment
Blinding of
participants
and personnel
Blinding of
outcome
assessment
Completion
rate (%)
(Treatment/
Placebo)
Intention-to-
treat
described
Incomplete
outcome data
adequately
addressed
Selective
outcome
reporting
Lyon Diet Heart
Study, de Lorgeril
et al (1994)
Yes Yes No Yes 90.1/87.4 Yes Yes No
Indo-
Mediterranean
Diet Study, Singh
et al (2002)
Yes Yes No Yes 98.2/97.8 Yes Yes No
Toobert et al
(2003)
Yes No No No 84/93.1 Yes Yes No
Burr et al (2003) Yes No No No 100/100 Yes Yes No
Ng et al (2011) Yes Yes No No 68/82.6 Yes Yes No
PREDIMED study,
Estruch et al
(2013)
Yes Yes No Yes 95.1/88.7 Yes Yes No
doi:10.1371/journal.pone.0159252.t002
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Fig 2. Forrest plot of the included studies showing relative risk of Mediterranean diet compared to control diet by
various outcomemeasures (Fixed effects model analysis).
doi:10.1371/journal.pone.0159252.g002
Effects of the Mediterranean Diet
PLOS ONE | DOI:10.1371/journal.pone.0159252 August 10, 2016 7 / 11
(MOS -12) short form general health survey[23] (all p>0.05). No data were available on new
onset type 2 diabetes mellitus, end-stage kidney disease or adverse events for any of the
included studies.
Discussion
This systematic review and meta-analysis supports the beneficial effects of the Mediterranean
diet on cardiovascular outcomes, although the quantity and quality of the available evidence is
relatively limited and there is much greater uncertainty about the effects of the Mediterranean
diet than is widely understood as a result. There are also no data about adverse outcomes
reported by any study, creating difficulties in the understanding of the overall balance between
the risks and benefits of the Mediterranean diet. While the completed trials suggest it is likely
that the Mediterranean diet protects against certain types of vascular diseases the evidence base
falls short of that required to make definitive conclusions or firm recommendations.
Underpinning the rationale for the large-scale outcome trials were the findings of a series of
prospective cohort studies[5–7] and recent reviews of those studies that reported moderately
decreased risks of all-cause mortality, cardiovascular mortality and the incidence of cardiovas-
cular disease associated with a Mediterranean diet[24,25]. However, observational studies of
the effects of diet on cardiovascular disease are highly prone to confounding and it is hard to
infer causation from these types of studies. Also in support of protective effects are the data
from smaller RCTs examining the effects of Mediterranean diet on intermediate metabolic out-
comes. These trials show small to moderate beneficial effects for multiple determinants of vas-
cular risk[26–28]. A recent overview of these RCTs trials identified blood pressure falls of
2.4mmHg (1.2 to 3.5) systolic and 1.6mmHg (1.1 to 2.0) diastolic, an LDL reduction of 2.71
mg/dl (5.03 to 0.39), a reduction in serum triglycerides of 6.14mg/dl (1.93 to 10.35) and an ele-
vation in HDL cholesterol of 1.17mg/dl (0.38 to 1.96)[12].
Despite these encouraging findings, neither the cohort studies nor the RCTs of intermediate
outcomes show benefits of a magnitude congruent with the very large point estimates of effect
on cardiovascular outcomes proposed by some of the individual trials included in our review.
Furthermore, while several other potential mechanisms of benefit such as antioxidant or anti-
inflammatory effects have been postulated for the Mediterranean diet[29,30], large trials of
intervention strategies specially targeting these pathways have been universally negative[31].
This raises an important question about the plausibility of large beneficial effects of the Medi-
terranean diet and raises concern about the possible effects of random or systematic errors. In
regard to the former, the total volume of data available is small and much less than might typi-
cally be available for comparable investigations of the effects of drugs on the same outcomes.
In terms of possible systematic errors, the un-masked design of the studies is a substantial
weakness inherent in the nature of the intervention and may have led to differential ascertain-
ment and assignment of outcomes across randomised groups. The much greater estimated
treatment effects on more subjective outcomes like coronary events, strokes and heart failure
compared to the non-significant estimates of effect for the objective outcome of mortality rein-
forces this possibility.
This review benefits from its comprehensive, systematic approach and the broad range of
clinically important endpoints considered (S4 File). It does, however, suffer from a number of
limitations. We could not explore heterogeneity across the individual study results for key out-
comes in detail and our analyses based upon limited published summary data are restricted in
their capacity to investigate this. Heterogeneity seems a possibility not only due to the different
nature of the interventions used across the trials but also due to a combination of factors such
as differing outcome definitions and varied durations of follow-up. In addition, the fact that
Effects of the Mediterranean Diet
PLOS ONE | DOI:10.1371/journal.pone.0159252 August 10, 2016 8 / 11
larger benefits were seen in smaller, single-centre studies with incomplete follow up raises the
possibility of overestimation of benefits by these studies. The absence of any data about the
risks of adverse events is also a significant short-coming. Another issue affecting the evidence
base supporting the use of the Mediterranean is the concern about the integrity of the trial by
Singh et al.[19]. Following a site visit organized by the Lancet to Dr. Singh’s research facility
due to concerns raised by multiple parties, including then the editor of BMJ, it was concluded
that it was not possible to be sure of the rigor for recording data and its handling. While unable
to point to specific evidence to refute the study's results, they raised concerns about the quality
of the data likely to be generated from a research facility that lacked access to the kind of highly
qualified support staff necessary to conduct a clinical trial to sufficiently high international
standards. These concerns have been extensively reported and it is clear that the conduct and
reporting of the trial are so weak as to raise serious concerns about the trial results[15]. If the
Mediterranean diet was seeking registration or reimbursement under any regulatory assess-
ment scheme it seems very unlikely that the data provided by the Singh trial would be eligible
to contribute. Accordingly the best current estimates of the effect of the Mediterranean diet on
cardiovascular outcomes are those that exclude the data from that study.
Conclusion
The American Heart Association/American College of Cardiology[32], the European Society
of Cardiology[33] and the National Heart Foundation of Australia (www.heartfoundation.org.
au) are three societies that all recommend the Mediterranean diet to reduce cardiovascular
risk. All are careful to base this advice on the observed favorable although modest effects of the
Mediterranean diet on intermediate cardiovascular risk factors. Clearly, recommendations
based upon definitive clinical outcomes would be far preferable, and are supported by the find-
ings of this review, however the strength of conclusions should remain circumspect because of
the weakness of the evidence base. It seems unlikely that clinicians and patients fully appreciate
the limitations of the data and the extent of the uncertainty. This is an area that warrants
another well-conducted, adequately powered trial able to precisely and reliably define the over-
all balance of benefits and risks associated with the Mediterranean diet.
Prior Presentations of Results
This work has been presented at the American College of Cardiology Annual Scientific Ses-
sions in 2015 in abstract form. The abstract is available from the following link: http://content.
onlinejacc.org/article.aspx?articleid=2198774
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